Skip to content

Gross margin at other companies

Baxter International logo
Baxter InternationalBAX
30.1%-5.9pp
Becton, Dickinson and Company logo
Becton, Dickinson and CompanyBDX
46.8%+2.5pp
Option Care Health, Inc. logo
Option Care Health, Inc.OPCH
19.2%-0.8pp
Viemed Healthcare, Inc. logo
Viemed Healthcare, Inc.VMD
57.6%-1.1pp
UFP Technologies logo
UFP TechnologiesUFPT
28.4%-0.6pp
ICU Medical logo
ICU MedicalICUI
37.9%+2.8pp

Other financials

Income statement

See full
Revenue$33.7M-3.0%
Gross profit$19.7M+2.7%
Operating income$1.6M+157%
Net income$1.0M+481%
EPS (diluted)$0.05+600%

Balance sheet

See full
Cash & equivalents$2.1M+39.8%
Total debt$24.1M-30.4%
Total equity$58.7M+6.5%
Total assets$98.7M-5.4%

Cash flow

See full
Operating cash flow$970.0K-45.5%
CapEx$157.0K+19.8%
Free cash flow$813.0K-50.7%

Valuation

See full
Market cap$205.05M+51.3%
Enterprise value$227.04M+36.2%
P/E25.9×-0.8×
P/S1.4×+0.5×

Profitability

See full
Operating margin9.1%+3.0pp
Net margin5.6%+3.2pp
FCF margin16.2%+1.0pp

Returns & leverage

See full
Return on equity13.9%+8.0pp
Debt / equity0.4×-0.2×
Current ratio2.1×-0.1×

Where this comes from

Calculated from InfuSystem Holdings’s reported figures.

Based on trailing twelve months.

The official record: InfuSystem Holdings’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about InfuSystem Holdings's gross margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is InfuSystem Holdings's gross margin?
InfuSystem Holdings (INFU) reported gross margin of 56.7% in Q1 2026.
How has InfuSystem Holdings's gross margin changed year-over-year?
InfuSystem Holdings's gross margin increased by 6.8% year-over-year, from 53.1% to 56.7%.
What is the long-term trend for InfuSystem Holdings's gross margin?
Over 5 years (2020 to 2025), InfuSystem Holdings's gross margin has grown at a -1.5% compound annual growth rate (CAGR), from 60.3% to 56%.
What does gross margin mean?
Gross profit (revenue minus cost of revenue) as a percentage of revenue, on a trailing-twelve-month basis. Measures how much of each sales dollar survives the direct cost of producing the goods or services sold.